ipragliflozin

chemokine (C-C motif) ligand 2 ; Mus musculus







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 27833913 Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse. 2016 2
2 23707905 Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice. 2013 Sep 5 1